ImmuneRegen BioSciences Holdings Inc. Establishes Research Entity in Singapore
Biotech Company to Test for Efficacy in Treating SARS, Avian Flu, Toxic Inhalation
31-Mar-2004 -
IR BioSciences Holdings, Inc., owner of biotechnology research and development company ImmuneRegen BioSciences, Inc., announced it has established a research entity in Singapore and has created IMM BioSciences Asia, Ltd. IR BioSciences Holdings, Inc. will license the use of its proprietary ...
avian influenza
Bio-Medical Science
biotechnology
+1